{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:23:17Z","timestamp":1791397397078,"version":"4.3.3"},"reference-count":82,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1053\/j.seminhematol.2013.11.007","type":"journal-article","created":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T22:46:47Z","timestamp":1384469207000},"page":"42-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Pathogenesis and Treatment of Extranodal Natural Killer\/T-Cell Lymphoma"],"prefix":"10.1053","volume":"51","author":[{"given":"Ritsuro","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2013.11.007_bib1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2141.2007.06835.x","article-title":"Progress in understanding and managing natural killer-cell malignancies","volume":"139","author":"Oshimi","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib2","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC","first-page":"285","article-title":"Extranodal NK\/T-cell lymphoma, nasal type","author":"Chan","year":"2008"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","article-title":"Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","article-title":"Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib5","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/annonc\/mdp418","article-title":"Prognostic factors for mature natural killer (NK)-cell neoplasms: aggressive NK-cell leukemia and extranodal NK-cell lymphoma, nasal-type","volume":"21","author":"Suzuki","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib6","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal NK\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-cell Lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib7","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1","article-title":"Frequent expression of P-glycoprotein\/MDR1 by nasal T-cell lymphoma cells","volume":"76","author":"Yamaguchi","year":"1995","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1182\/blood.V93.2.599","article-title":"P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833","volume":"93","author":"Egashira","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2141.2001.02885.x","article-title":"Evidence that natural killer cells express mini P-glycoproteins but not classic 170 kDa P-glycoprotein","volume":"114","author":"Trambas","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/A:1011144911781","article-title":"CHOP followed by involved field radiation: is it optimal for localized nasal natural killer\/T-cell lymphoma?","volume":"12","author":"Kim","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s12185-010-0720-8","article-title":"Treatment of localized extranodal NK\/T cell lymphoma, nasal type","volume":"92","author":"Kim","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s12185-010-0726-2","article-title":"Treatment of advanced extranodal NK\/T cell lymphoma, nasal-type and aggressive NK-cell leukemia","volume":"92","author":"Suzuki","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib13","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1046\/j.1365-2141.1997.3223139.x","article-title":"Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma\/leukaemia","volume":"98","author":"Wong","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2141.1997.752711.x","article-title":"Clonal chromosomal abnormalities as direct evidence for clonality in nasal T\/natural killer cell lymphomas","volume":"97","author":"Tien","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib15","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9440(10)65454-5","article-title":"Comparative genomic hybridization analysis of natural killer cell lymphoma\/leukemia. Recognition of consistent patterns of genetic alterations","volume":"155","author":"Siu","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/gcc.20245","article-title":"Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK\/T-cell lymphoma, nasal type","volume":"44","author":"Nakashima","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib17","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2009.3","article-title":"Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies","volume":"23","author":"Iqbal","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood-2009-11-252957","article-title":"Cutaneous extranodal NK\/T-cell lymphoma: a clinicopathologic study of 5 patients with array-based comparative genomic hybridization","volume":"116","author":"Berti","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib19","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1182\/blood-2011-04-346890","article-title":"Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses","volume":"118","author":"Karube","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1084\/jem.20052204","article-title":"Inactivation of the PRDM1\/BLIMP1 gene in diffuse large B cell lymphoma","volume":"203","author":"Pasqualucci","year":"2006","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib21","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1182\/blood-2005-09-3778","article-title":"Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas","volume":"107","author":"Tam","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib22","doi-asserted-by":"crossref","first-page":"20119","DOI":"10.1073\/pnas.1115128108","article-title":"PRDM1 is a tumor suppressor gene in natural killer cell malignancies","volume":"108","author":"K\u00fc\u00e7\u00fck","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3960\/jslrt.45.51","article-title":"Leukemia and lymphoma of natural killer cells","volume":"45","author":"Suzuki","year":"2005","journal-title":"J Clin Exp Hematopathol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/hon.847","article-title":"Extranodal NK\/T-cell lymphoma: diagnosis and treatment cues","volume":"26","author":"Suzuki","year":"2008","journal-title":"Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib25","first-page":"108","article-title":"Epstein-Barr virus-associated diseases in humans","volume":"71","author":"Kawa","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00000478-199601000-00012","article-title":"Report of the Workshop on Nasal and Related Extranodal Angiocentric T\/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology","volume":"20","author":"Jaffe","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib27","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1182\/blood.V83.8.2255.2255","article-title":"Expression of adult and fetal natural killer cell markers in sinonasal lymphomas","volume":"83","author":"Suzumiya","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib28","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood.V87.4.1466.bloodjournal8741466","article-title":"CD5- CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas","volume":"87","author":"Emile","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib29","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2559.1997.2880887.x","article-title":"Nasal T\/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage","volume":"31","author":"Ohshima","year":"1997","journal-title":"Histopathology"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib30","first-page":"699","article-title":"Expression of perforin in nasal lymphoma","volume":"149","author":"Mori","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib31","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2005-05-2056","article-title":"Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)\/II(E) extranodal NK\/T-cell lymphoma, nasal type","volume":"106","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<449::AID-CNCR13>3.0.CO;2-W","article-title":"Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy","volume":"83","author":"Li","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/cncr.11908","article-title":"Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer\/T-cell or T-cell lymphoma","volume":"100","author":"Li","year":"2004","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib34","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/modpathol.3800157","article-title":"Nasal-type extranodal natural killer\/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore","volume":"17","author":"Ng","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib35","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/00000478-199911000-00006","article-title":"Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital","volume":"23","author":"Cuadra-Garcia","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-2257.2000.00307.x","article-title":"Angiocentric nasal T\/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients","volume":"22","author":"Aviles","year":"2000","journal-title":"Clin Lab Haematol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.pai.0000205062.27174.56","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru","volume":"15","author":"Barrionuevo","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib38","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/PAS.0b013e31821ec4b5","article-title":"Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK\/T-cell lymphoma, nasal type, with EBV subtyping analysis","volume":"35","author":"Gualco","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1756-8722-5-27","article-title":"Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK\/T cell lymphoma","volume":"5","author":"Chauchet","year":"2012","journal-title":"J Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/PAS.0b013e31824433d8","article-title":"Extranodal NK\/T-cell lymphoma, nasal type, includes cases of natural killer cell and \u03b1\u03b2, \u03b3\u03b4, and \u03b1\u03b2\/\u03b3\u03b4 T-cell origin: a comprehensive clinicopathologic and phenotypic study","volume":"36","author":"Pongpruttipan","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib41","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1182\/blood-2009-03-211011","article-title":"Differences between nasal and extra-nasal NK\/T-cell lymphoma","volume":"113","author":"Suzuki","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib42","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.1998.16.1.70","article-title":"Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients","volume":"16","author":"Cheung","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2000.18.1.54","article-title":"Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment","volume":"18","author":"Kim","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib45","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/annonc\/mdh143","article-title":"Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)\/T-cell lymphoma: a single institute survey in Taiwan","volume":"15","author":"You","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib46","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/10428190600565651","article-title":"Treatment outcome of front-line systemic chemotherapy for localized extranodal NK\/T cell lymphoma in nasal and upper aerodigestive tract","volume":"47","author":"Kim","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","article-title":"Radiotherapy as primary treatment for stage IE and IIE nasal natural killer\/T-cell lymphoma","volume":"24","author":"Li","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib48","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","article-title":"Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211","volume":"27","author":"Yamaguchi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib49","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","article-title":"Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-cell lymphoma: Consortium for Improving Survival of Lymphoma Study","volume":"27","author":"Kim","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib50","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1200\/JCO.2012.45.6541","article-title":"Concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211","volume":"30","author":"Yamaguchi","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib51","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF02982090","article-title":"L-asparaginase induced durable remission of relapsed nasal NK\/T-cell lymphoma after autologous peripheral blood stem cell transplantation","volume":"74","author":"Nagafuji","year":"2001","journal-title":"Int J Hematol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib52","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF02983802","article-title":"L-asparaginase-based induction therapy for advanced extranodal NK\/T-cell lymphoma","volume":"78","author":"Obama","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib53","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/1042819031000067873","article-title":"Successful treatment with Erwinia L-asparaginase for recurrent natural killer\/T cell lymphoma","volume":"44","author":"Matsumoto","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib54","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1365-2141.2005.05694.x","article-title":"Selective apoptosis of natural killer-cell tumours by l-asparaginase","volume":"130","author":"Ando","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib55","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1349-7006.2008.00768.x","article-title":"Phase I study of dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)\/T-cell lymphoma and leukemia","volume":"99","author":"Yamaguchi","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib56","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","article-title":"Phase II study of SMILE chemotherapy for newly-diagnosed stage IV, relapsed or refractory extranodal NK\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group (NKTSG) study","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib57","first-page":"175","article-title":"Long-term follow-up of the phase II study of SMILE chemotherapy for patients with newly diagnosed stage IV, relapsed or refractory extranodal NK\/T-cell lymphoma, nasal type: the NK-cell Tumor Study Group study","volume":"31 suppl. S1","author":"Suzuki","year":"2013","journal-title":"Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib58","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/annonc\/mdn542","article-title":"l-Asparaginase-based treatment of 15 western patients with extranodal NK\/T-cell lymphoma and leukemia and a review of the literature","volume":"20","author":"Jaccard","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib59","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood-2010-09-307454","article-title":"Efficacy of l-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK\/T-cell lymphoma, a phase II study","volume":"117","author":"Jaccard","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib60","first-page":"129","article-title":"A prospective phase II trial of an L-asparaginase containing regimen in extranodal NK\/T-cell lymphoma","volume":"31 suppl S1","author":"Jaccard","year":"2013","journal-title":"Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib61","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/annonc\/mdg458","article-title":"Autologous stem cell transplantation for nasal NK\/T-cell lymphoma: a progress report on its value","volume":"14","author":"Au","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib62","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bmt.1705244","article-title":"Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms","volume":"37","author":"Suzuki","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib63","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bmt.1705349","article-title":"High-dose chemotherapy with autologous stem cell transplantation in extranodal NK\/T-cell lymphoma: a retrospective comparison with non-transplantation cases","volume":"37","author":"Kim","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib64","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.bbmt.2008.09.014","article-title":"Autologous hematopoietic stem cell transplantation in extranodal NK\/T-cell lymphoma: a multinational, multicenter, matched controlled study","volume":"14","author":"Lee","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib65","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2005.05651.x","article-title":"Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms","volume":"130","author":"Murashige","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib66","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1182\/blood.V118.21.503.503","article-title":"Comparison of autologous and allogeneic hematopoietic stem cell transplantation for extranodal NK\/T-cell lymphoma, nasal-type: analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group","volume":"118","author":"Suzuki","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib67","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/340393a0","article-title":"Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes","volume":"340","author":"Hammerschmidt","year":"1989","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib68","first-page":"1856","article-title":"Circulating Epstein-Barr virus DNA in the serum of patients with gastric carcinoma","volume":"7","author":"Dennis","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib69","first-page":"2028","article-title":"Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients","volume":"63","author":"Chan","year":"2003","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib70","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","article-title":"Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients","volume":"104","author":"Au","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib71","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1182\/blood-2011-05-354142","article-title":"Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK\/T-cell lymphoma, nasal type","volume":"118","author":"Suzuki","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib72","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1158\/1078-0432.CCR-12-1064","article-title":"Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK\/T-cell lymphoma, nasal type","volume":"18","author":"Ito","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib73","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/rmv.582","article-title":"Measuring Epstein-Barr virus (EBV) load: its significance and application in each EBV-associated disease","volume":"18","author":"Kimura","year":"2008","journal-title":"Rev Med Virol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib74","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.leu.2403262","article-title":"Aggressive natural killer (NK)-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells","volume":"18","author":"Suzuki","year":"2004","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib75","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1349-7006.2012.02251.x","article-title":"Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation","volume":"103","author":"Ishida","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib76","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib77","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3109\/10428194.2012.720374","article-title":"Successful disease control with l-asparaginase monotherapy for aggressive natural killer cell leukemia with severe hepatic failure","volume":"54","author":"Takahashi","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib78","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00000478-200604000-00017","article-title":"Atypical NK-cell proliferation of the gastrointestinal tract in a patient with antigliadin antibodies but not celiac disease","volume":"30","author":"Vega","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib79","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1182\/blood-2010-06-290650","article-title":"Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation","volume":"116","author":"Takeuchi","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib80","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1182\/blood-2010-08-302737","article-title":"NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series","volume":"117","author":"Mansoor","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib81","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1182\/blood.V84.8.2721.2721","article-title":"Chronic natural killer cell lymphocytosis: a descriptive clinical study","volume":"84","author":"Tefferi","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2013.11.007_bib82","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V81.10.2723.2723","article-title":"Failure to detect Epstein-Barr virus DNA in peripheral blood mononuclear cells of most patients with large granular lymphocyte leukemia","volume":"81","author":"Loughran","year":"1993","journal-title":"Blood"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196313001571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196313001571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:22:02Z","timestamp":1758522122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196313001571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0037196313001571"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2013.11.007","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis and Treatment of Extranodal Natural Killer\/T-Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2013.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}